Laboratory of Neurobiology, Department of Pathology and Experimental Therapy, Institute of Neurosciences, University of Barcelona, Barcelona, Spain ...

HanchorBio today announced that its proprietary HCB101, a SIRPa/CD47 fusion protein candidate, has been officially granted a US patent (Patent No.

(Nasdaq: SPRO) and GSK plc (LSE/NYSE: GSK) today announced efficacy and safety results of the positive pivotal phase 3 PIVOT-PO trial evaluating tebipenem HBr, an investigational oral treatment for ...

Developing new topical drugs or cosmetics requires a long, expensive research and marketing process, with each launch ...

TAIPEI and SHANGHAI and SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ — HanchorBio today announced that its proprietary HCB101, a SIRPα/CD47 fusion protein candidate, has been officially granted a US ...

Witness the behind-the-scenes delivery of the impressive life-sized Lamborghini Sian model built mostly from LEGO bricks, now ...